Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Author Profile Past 90 Days 71 stories 1 Publishers

frank vinluan

No author bio on file yet.

Social profiles not yet on file.
frank vinluan's Coverage
Buzz
Media Coverage
World View
Beat Reporting
Category Articles Share
Health_Medical_Pharma 65
Business_Finance 5
Entertainment_Culture 1

Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva
2026-10-27 — medcitynews.com


Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3
2026-10-26 — medcitynews.com


Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science
2026-10-25 — medcitynews.com


Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J’s New Immunology Pill
2026-10-23 — medcitynews.com


Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition
2026-10-22 — medcitynews.com


GSK Wins FDA Nod for Novel Hepatitis B Drug Offering a Potential Functional Cure
2026-10-21 — medcitynews.com


GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer
2026-10-20 — medcitynews.com


Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer
2026-10-19 — medcitynews.com


Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
2026-10-18 — medcitynews.com


City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver
2026-10-16 — medcitynews.com

Execution: 0.23 Seconds. 24.81 mb used.